词条 | Cell culture | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
释义 |
Cell culture is the process by which cells are grown under controlled conditions, generally outside their natural environment. After the cells of interest have been isolated from living tissue, they can subsequently be maintained under carefully controlled conditions. These conditions vary for each cell type, but generally consist of a suitable vessel with a substrate or medium that supplies the essential nutrients (amino acids, carbohydrates, vitamins, minerals), growth factors, hormones, and gases (CO2, O2), and regulates the physio-chemical environment (pH buffer, osmotic pressure, temperature). Most cells require a surface or an artificial substrate (adherent or monolayer culture) whereas others can be grown free floating in culture medium (suspension culture). The lifespan of most cells is genetically determined, but some cell culturing cells have been “transformed” into immortal cells which will reproduce indefinitely if the optimal conditions are provided. In practice, the term "cell culture" now refers to the culturing of cells derived from multicellular eukaryotes, especially animal cells, in contrast with other types of culture that also grow cells, such as plant tissue culture, fungal culture, and microbiological culture (of microbes). The historical development and methods of cell culture are closely interrelated to those of tissue culture and organ culture. Viral culture is also related, with cells as hosts for the viruses. The laboratory technique of maintaining live cell lines (a population of cells descended from a single cell and containing the same genetic makeup) separated from their original tissue source became more robust in the middle 20th century.[1][2] HistoryThe 19th-century English physiologist Sydney Ringer developed salt solutions containing the chlorides of sodium, potassium, calcium and magnesium suitable for maintaining the beating of an isolated animal heart outside the body.[3] In 1885, Wilhelm Roux removed a portion of the medullary plate of an embryonic chicken and maintained it in a warm saline solution for several days, establishing the principle of tissue culture.[4] Ross Granville Harrison, working at Johns Hopkins Medical School and then at Yale University, published results of his experiments from 1907 to 1910, establishing the methodology of tissue culture.[5] Cell culture techniques were advanced significantly in the 1940s and 1950s to support research in virology. Growing viruses in cell cultures allowed preparation of purified viruses for the manufacture of vaccines. The injectable polio vaccine developed by Jonas Salk was one of the first products mass-produced using cell culture techniques. This vaccine was made possible by the cell culture research of John Franklin Enders, Thomas Huckle Weller, and Frederick Chapman Robbins, who were awarded a Nobel Prize for their discovery of a method of growing the virus in monkey kidney cell cultures. Concepts in mammalian cell cultureIsolation of cells{{Main|Cell isolation}}Cells can be isolated from tissues for ex vivo culture in several ways. Cells can be easily purified from blood; however, only the white cells are capable of growth in culture. Cells can be isolated from solid tissues by digesting the extracellular matrix using enzymes such as collagenase, trypsin, or pronase, before agitating the tissue to release the cells into suspension.[6][7] Alternatively, pieces of tissue can be placed in growth media, and the cells that grow out are available for culture. This method is known as explant culture.Cells that are cultured directly from a subject are known as primary cells. With the exception of some derived from tumors, most primary cell cultures have limited lifespan. An established or immortalized cell line has acquired the ability to proliferate indefinitely either through random mutation or deliberate modification, such as artificial expression of the telomerase gene. Numerous cell lines are well established as representative of particular cell types. Maintaining cells in cultureFor the majority of isolated primary cells, they undergo the process of senescence and stop dividing after a certain number of population doublings while generally retaining their viability (described as the Hayflick limit). Cells are grown and maintained at an appropriate temperature and gas mixture (typically, 37 °C, 5% CO2 for mammalian cells) in a cell incubator. Culture conditions vary widely for each cell type, and variation of conditions for a particular cell type can result in different phenotypes.Aside from temperature and gas mixture, the most commonly varied factor in culture systems is the cell growth medium. Recipes for growth media can vary in pH, glucose concentration, growth factors, and the presence of other nutrients. The growth factors used to supplement media are often derived from the serum of animal blood, such as fetal bovine serum (FBS), bovine calf serum, equine serum, and porcine serum. One complication of these blood-derived ingredients is the potential for contamination of the culture with viruses or prions, particularly in medical biotechnology applications. Current practice is to minimize or eliminate the use of these ingredients wherever possible and use human platelet lysate (hPL).[8] This eliminates the worry of cross-species contamination when using FBS with human cells. hPL has emerged as a safe and reliable alternative as a direct replacement for FBS or other animal serum. In addition, chemically defined media can be used to eliminate any serum trace (human or animal), but this cannot always be accomplished with different cell types. Alternative strategies involve sourcing the animal blood from countries with minimum BSE/TSE risk, such as The United States, Australia and New Zealand,[9] and using purified nutrient concentrates derived from serum in place of whole animal serum for cell culture.[10] Plating density (number of cells per volume of culture medium) plays a critical role for some cell types. For example, a lower plating density makes granulosa cells exhibit estrogen production, while a higher plating density makes them appear as progesterone-producing theca lutein cells.[11]Cells can be grown either in suspension or adherent cultures. Some cells naturally live in suspension, without being attached to a surface, such as cells that exist in the bloodstream. There are also cell lines that have been modified to be able to survive in suspension cultures so they can be grown to a higher density than adherent conditions would allow. Adherent cells require a surface, such as tissue culture plastic or microcarrier, which may be coated with extracellular matrix (such as collagen and laminin) components to increase adhesion properties and provide other signals needed for growth and differentiation. Most cells derived from solid tissues are adherent. Another type of adherent culture is organotypic culture, which involves growing cells in a three-dimensional (3-D) environment as opposed to two-dimensional culture dishes. This 3D culture system is biochemically and physiologically more similar to in vivo tissue, but is technically challenging to maintain because of many factors (e.g. diffusion). Components of cell culture media
Typical Growth conditions
Cell line cross-contamination{{Main|List of contaminated cell lines}}Cell line cross-contamination can be a problem for scientists working with cultured cells.[12] Studies suggest anywhere from 15–20% of the time, cells used in experiments have been misidentified or contaminated with another cell line.[13][14][15] Problems with cell line cross-contamination have even been detected in lines from the NCI-60 panel, which are used routinely for drug-screening studies.[16][17] Major cell line repositories, including the American Type Culture Collection (ATCC), the European Collection of Cell Cultures (ECACC) and the German Collection of Microorganisms and Cell Cultures (DSMZ), have received cell line submissions from researchers that were misidentified by them.[16][18] Such contamination poses a problem for the quality of research produced using cell culture lines, and the major repositories are now authenticating all cell line submissions.[19] ATCC uses short tandem repeat (STR) DNA fingerprinting to authenticate its cell lines.[20] To address this problem of cell line cross-contamination, researchers are encouraged to authenticate their cell lines at an early passage to establish the identity of the cell line. Authentication should be repeated before freezing cell line stocks, every two months during active culturing and before any publication of research data generated using the cell lines. Many methods are used to identify cell lines, including isoenzyme analysis, human lymphocyte antigen (HLA) typing, chromosomal analysis, karyotyping, morphology and STR analysis.[20] One significant cell-line cross contaminant is the immortal HeLa cell line. Other technical issuesAs cells generally continue to divide in culture, they generally grow to fill the available area or volume. This can generate several issues:
Manipulation of cultured cellsAmong the common manipulations carried out on culture cells are media changes, passaging cells, and transfecting cells. These are generally performed using tissue culture methods that rely on aseptic technique. Aseptic technique aims to avoid contamination with bacteria, yeast, or other cell lines. Manipulations are typically carried out in a biosafety cabinet or laminar flow cabinet to exclude contaminating micro-organisms. Antibiotics (e.g. penicillin and streptomycin) and antifungals (e.g.amphotericin B) can also be added to the growth media. As cells undergo metabolic processes, acid is produced and the pH decreases. Often, a pH indicator is added to the medium to measure nutrient depletion. Media changesIn the case of adherent cultures, the media can be removed directly by aspiration, and then is replaced. Media changes in non-adherent cultures involve centrifuging the culture and resuspending the cells in fresh media. Passaging cells{{main|Passaging}}Passaging (also known as subculture or splitting cells) involves transferring a small number of cells into a new vessel. Cells can be cultured for a longer time if they are split regularly, as it avoids the senescence associated with prolonged high cell density. Suspension cultures are easily passaged with a small amount of culture containing a few cells diluted in a larger volume of fresh media. For adherent cultures, cells first need to be detached; this is commonly done with a mixture of trypsin-EDTA; however, other enzyme mixes are now available for this purpose. A small number of detached cells can then be used to seed a new culture. Some cell cultures, such as RAW cells are mechanically scraped from the surface of their vessel with rubber scrapers. Transfection and transduction{{main|Transfection|Transformation (genetics)}}Another common method for manipulating cells involves the introduction of foreign DNA by transfection. This is often performed to cause cells to express a gene of interest. More recently, the transfection of RNAi constructs have been realized as a convenient mechanism for suppressing the expression of a particular gene/protein. DNA can also be inserted into cells using viruses, in methods referred to as transduction, infection or transformation. Viruses, as parasitic agents, are well suited to introducing DNA into cells, as this is a part of their normal course of reproduction. Established human cell linesCell lines that originate with humans have been somewhat controversial in bioethics, as they may outlive their parent organism and later be used in the discovery of lucrative medical treatments. In the pioneering decision in this area, the Supreme Court of California held in Moore v. Regents of the University of California that human patients have no property rights in cell lines derived from organs removed with their consent.[22] {{details|Hybridoma}}It is possible to fuse normal cells with an immortalised cell line. This method is used to produce monoclonal antibodies. In brief, lymphocytes isolated from the spleen (or possibly blood) of an immunised animal are combined with an immortal myeloma cell line (B cell lineage) to produce a hybridoma which has the antibody specificity of the primary lymphocyte and the immortality of the myeloma. Selective growth medium (HA or HAT) is used to select against unfused myeloma cells; primary lymphoctyes die quickly in culture and only the fused cells survive. These are screened for production of the required antibody, generally in pools to start with and then after single cloning. Cell strainsA cell strain is derived either from a primary culture or a cell line by the selection or cloning of cells having specific properties or characteristics which must be defined. Cell strains are cells that have been adapted to culture but, unlike cell lines, have a finite division potential. Non-immortalized cells stop dividing after 40 to 60 population doublings[23] and, after this, they lose their ability to proliferate (a genetically determined event known as senescence).[24] Applications of cell cultureMass culture of animal cell lines is fundamental to the manufacture of viral vaccines and other products of biotechnology. Culture of human stem cells is used to expand the number of cells and differentiate the cells into various somatic cell types for transplantation.[25] Stem cell culture is also used to harvest the molecules and exosomes that the stem cells release for the purposes of therapeutic development.[26] Biological products produced by recombinant DNA (rDNA) technology in animal cell cultures include enzymes, synthetic hormones, immunobiologicals (monoclonal antibodies, interleukins, lymphokines), and anticancer agents. Although many simpler proteins can be produced using rDNA in bacterial cultures, more complex proteins that are glycosylated (carbohydrate-modified) currently must be made in animal cells. An important example of such a complex protein is the hormone erythropoietin. The cost of growing mammalian cell cultures is high, so research is underway to produce such complex proteins in insect cells or in higher plants, use of single embryonic cell and somatic embryos as a source for direct gene transfer via particle bombardment, transit gene expression and confocal microscopy observation is one of its applications. It also offers to confirm single cell origin of somatic embryos and the asymmetry of the first cell division, which starts the process. Cell culture is also a key technique for cellular agriculture, which aims to provide both new products and new ways of producing existing agricultural products like milk, (cultured) meat, fragrances, and rhino horn from cells and microorganisms. It is therefore considered one means of achieving animal-free agriculture. It is also a central tool for teaching cell biology.[27] Cell culture in two dimensionsResearch in tissue engineering, stem cells and molecular biology primarily involves cultures of cells on flat plastic dishes. This technique is known as two-dimensional (2D) cell culture, and was first developed by Wilhelm Roux who, in 1885, removed a portion of the medullary plate of an embryonic chicken and maintained it in warm saline for several days on a flat glass plate. From the advance of polymer technology arose today's standard plastic dish for 2D cell culture, commonly known as the Petri dish. Julius Richard Petri, a German bacteriologist, is generally credited with this invention while working as an assistant to Robert Koch. Various researchers today also utilize culturing laboratory flasks, conicals, and even disposable bags like those used in single-use bioreactors. Aside from Petri dishes, scientists have long been growing cells within biologically derived matrices such as collagen or fibrin, and more recently, on synthetic hydrogels such as polyacrylamide or PEG. They do this in order to elicit phenotypes that are not expressed on conventionally rigid substrates. There is growing interest in controlling matrix stiffness,[28] a concept that has led to discoveries in fields such as:
Cell culture in three dimensionsCell culture in three dimensions has been touted as "Biology's New Dimension".[43] At present, the practice of cell culture remains based on varying combinations of single or multiple cell structures in 2D.[44] Currently, there is an increase in use of 3D cell cultures in research areas including drug discovery, cancer biology, regenerative medicine and basic life science research.[45] 3D cell cultures can be grown using a scaffold or matrix, or in a scaffold-free manner. Scaffold based cultures utilize an acellular 3D matrix or a liquid matrix. Scaffold-free methods are normally generated in suspensions.[46] There are a variety of platforms used to facilitate the growth of three-dimensional cellular structures including scaffold systems such as hydrogel matrices[47] and solid scaffolds, and scaffold-free systems such as low-adhesion plates, nanoparticle facilitated magnetic levitation,[48] and hanging drop plates.[49]3D cell culture in scaffoldsEric Simon, in a 1988 NIH SBIR grant report, showed that electrospinning could be used to produced nano- and submicron-scale polystyrene and polycarbonate fibrous scaffolds specifically intended for use as in vitro cell substrates. This early use of electrospun fibrous lattices for cell culture and tissue engineering showed that various cell types including Human Foreskin Fibroblasts (HFF), transformed Human Carcinoma (HEp-2), and Mink Lung Epithelium (MLE) would adhere to and proliferate upon polycarbonate fibers. It was noted that, as opposed to the flattened morphology typically seen in 2D culture, cells grown on the electrospun fibers exhibited a more histotypic rounded 3-dimensional morphology generally observed in vivo.[50] 3D cell culture in hydrogelsAs the natural extracellular matrix (ECM) is important in the survival, proliferation, differentiation and migration of cells, different hydrogel culture matrices mimicking natural ECM structure are seen as potential approaches to in vivo –like cell culturing.[51] Hydrogels are composed of interconnected pores with high water retention, which enables efficient transport of substances such as nutrients and gases. Several different types of hydrogels from natural and synthetic materials are available for 3D cell culture, including animal ECM extract hydrogels, protein hydrogels, peptide hydrogels, polymer hydrogels, and wood-based nanocellulose hydrogel. 3D Cell Culturing by Magnetic LevitationThe 3D Cell Culturing by Magnetic Levitation method (MLM) is the application of growing 3D tissue by inducing cells treated with magnetic nanoparticle assemblies in spatially varying magnetic fields using neodymium magnetic drivers and promoting cell to cell interactions by levitating the cells up to the air/liquid interface of a standard petri dish. The magnetic nanoparticle assemblies consist of magnetic iron oxide nanoparticles, gold nanoparticles, and the polymer polylysine. 3D cell culturing is scalable, with the capability for culturing 500 cells to millions of cells or from single dish to high-throughput low volume systems. Tissue culture and engineeringCell culture is a fundamental component of tissue culture and tissue engineering, as it establishes the basics of growing and maintaining cells in vitro. The major application of human cell culture is in stem cell industry, where mesenchymal stem cells can be cultured and cryopreserved for future use. Tissue engineering potentially offers dramatic improvements in low cost medical care for hundreds of thousands of patients annually. VaccinesVaccines for polio, measles, mumps, rubella, and chickenpox are currently made in cell cultures. Due to the H5N1 pandemic threat, research into using cell culture for influenza vaccines is being funded by the United States government. Novel ideas in the field include recombinant DNA-based vaccines, such as one made using human adenovirus (a common cold virus) as a vector,[52][53]and novel adjuvants.[54] Culture of non-mammalian cellsBesides the culture of well-established immortalised cell lines, cells from primary explants of a plethora of organisms can be cultured for a limited period of time before sensecence occurs (see Hayflick's limit). Cultured primary cells have been extensively used in research, as is the case of fish keratocytes in cell migration studies.[55][27][56] Plant cell culture methods{{main|Plant tissue culture}}{{see also|Tobacco BY-2 cells}}Plant cell cultures are typically grown as cell suspension cultures in a liquid medium or as callus cultures on a solid medium. The culturing of undifferentiated plant cells and calli requires the proper balance of the plant growth hormones auxin and cytokinin. Insect cell cultureCells derived from Drosophila melanogaster (most prominently, Schneider 2 cells) can be used for experiments which may be hard to do on live flies or larvae, such as biochemical studies or studies using siRNA. Cell lines derived from the army worm Spodoptera frugiperda, including Sf9 and Sf21, and from the cabbage looper Trichoplusia ni, High Five cells, are commonly used for expression of recombinant proteins using baculovirus. Bacterial and yeast culture methods{{main|Microbiological culture}}For bacteria and yeasts, small quantities of cells are usually grown on a solid support that contains nutrients embedded in it, usually a gel such as agar, while large-scale cultures are grown with the cells suspended in a nutrient broth. Viral culture methods{{main|Viral culture}}The culture of viruses requires the culture of cells of mammalian, plant, fungal or bacterial origin as hosts for the growth and replication of the virus. Whole wild type viruses, recombinant viruses or viral products may be generated in cell types other than their natural hosts under the right conditions. Depending on the species of the virus, infection and viral replication may result in host cell lysis and formation of a viral plaque. Common cell lines
List of cell lines{{Expand list|date=July 2011}}
See also
References and notes1. ^{{cite web|url=https://www.ncbi.nlm.nih.gov/books/bv.fcgi?db=Books&rid=mboc4.table.1516|title=Some landmarks in the development of tissue and cell culture|accessdate=2006-04-19}} 2. ^{{cite web|url=http://www.bioteach.ubc.ca/Bioengineering/CellCulture/index.htm|title=Cell Culture|accessdate=2006-04-19}} 3. ^{{cite web|url=http://www.whonamedit.com/synd.cfm/2119.html|title=Whonamedit - Ringer's solution|publisher=whonamedit.com|accessdate=2014-06-09}} 4. ^{{cite web|url=http://caat.jhsph.edu/pubs/animal_alts/appendix_c.htm|title=Animals and alternatives in testing|accessdate=2006-04-19|archiveurl = https://web.archive.org/web/20060225204205/http://caat.jhsph.edu/pubs/animal_alts/appendix_c.htm |archivedate = 2006-02-25}} 5. ^{{cite web | last = Schiff | first = JudithAnn | name-list-format = vanc | title=An unsung hero of medical research | url = http://www.yalealumnimagazine.com/issues/02_02/old_yale.html|accessdate=2006-04-19 | work = Yale Alumni Magazine | date = February 2002 }} 6. ^{{cite journal | vauthors = Voigt N, Pearman CM, Dobrev D, Dibb KM | title = Methods for isolating atrial cells from large mammals and humans | journal = Journal of Molecular and Cellular Cardiology | volume = 86 | pages = 187–98 | date = September 2015 | doi = 10.1016/j.yjmcc.2015.07.006 | pmid = 26186893 }} 7. ^{{cite journal | vauthors = Louch WE, Sheehan KA, Wolska BM | title = Methods in cardiomyocyte isolation, culture, and gene transfer | journal = Journal of Molecular and Cellular Cardiology | volume = 51 | issue = 3 | pages = 288–98 | date = September 2011 | pmc = 3164875 | doi = 10.1016/j.yjmcc.2011.06.012 | pmid = 21723873 }} 8. ^Hemeda, H., Giebel, B., Wagner, W. (16Feb2014) Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells Cytotherapy p170-180 issue 2 doi.10.1016 9. ^{{cite web|url=http://www.bovalco.com/blog/post/view/9|title=Post - Blog | Boval BioSolutions, LLC|publisher=bovalco.com|accessdate=2014-12-02}} 10. ^{{cite web|url=http://www.selbornebiological.com/products/lipimax.htm|title=LipiMAX purified lipoprotein solution from bovine serum|year=2006|work=Selborne Biological Services|accessdate=2010-02-02}} 11. ^{{cite journal | vauthors = Portela VM, Zamberlam G, Price CA | title = Cell plating density alters the ratio of estrogenic to progestagenic enzyme gene expression in cultured granulosa cells | journal = Fertility and Sterility | volume = 93 | issue = 6 | pages = 2050–5 | date = April 2010 | pmid = 19324349 | doi = 10.1016/j.fertnstert.2009.01.151 }} 12. ^{{cite journal | vauthors = Neimark J | title = Line of attack | journal = Science | volume = 347 | issue = 6225 | pages = 938–40 | date = February 2015 | pmid = 25722392| pmc = | doi = 10.1126/science.347.6225.938 }} 13. ^{{cite journal | vauthors = Drexler HG, Dirks WG, MacLeod RA | title = False human hematopoietic cell lines: cross-contaminations and misinterpretations | journal = Leukemia | volume = 13 | issue = 10 | pages = 1601–7 | date = October 1999 | pmid = 10516762 | doi = 10.1038/sj/leu/2401510 }} 14. ^{{cite journal | vauthors = Drexler HG, MacLeod RA, Dirks WG | title = Cross-contamination: HS-Sultan is not a myeloma but a Burkitt lymphoma cell line | journal = Blood | volume = 98 | issue = 12 | pages = 3495–6 | date = December 2001 | pmid = 11732505 | doi = 10.1182/blood.V98.12.3495 }} 15. ^{{cite journal | vauthors = Cabrera CM, Cobo F, Nieto A, Cortés JL, Montes RM, Catalina P, Concha A | title = Identity tests: determination of cell line cross-contamination | journal = Cytotechnology | volume = 51 | issue = 2 | pages = 45–50 | date = June 2006 | pmid = 19002894 | pmc = 3449683 | doi = 10.1007/s10616-006-9013-8 }} 16. ^1 {{cite journal | vauthors = Chatterjee R | title = Cell biology. Cases of mistaken identity | journal = Science | volume = 315 | issue = 5814 | pages = 928–31 | date = February 2007 | pmid = 17303729 | doi = 10.1126/science.315.5814.928 }} 17. ^{{cite journal | vauthors = Liscovitch M, Ravid D | title = A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells | journal = Cancer Letters | volume = 245 | issue = 1–2 | pages = 350–2 | date = January 2007 | pmid = 16504380 | doi = 10.1016/j.canlet.2006.01.013 }} 18. ^{{cite journal | vauthors = MacLeod RA, Dirks WG, Matsuo Y, Kaufmann M, Milch H, Drexler HG | title = Widespread intraspecies cross-contamination of human tumor cell lines arising at source | journal = International Journal of Cancer | volume = 83 | issue = 4 | pages = 555–63 | date = November 1999 | pmid = 10508494 | doi = 10.1002/(SICI)1097-0215(19991112)83:4<555::AID-IJC19>3.0.CO;2-2 }} 19. ^{{cite journal | vauthors = Masters JR | title = HeLa cells 50 years on: the good, the bad and the ugly | journal = Nature Reviews. Cancer | volume = 2 | issue = 4 | pages = 315–9 | date = April 2002 | pmid = 12001993 | doi = 10.1038/nrc775 }} 20. ^1 {{cite journal | last1 = Dunham | first1 = J.H. | last2 = Guthmiller | first2 = P. | name-list-format = vanc | year = 2008 | title = Doing good science: Authenticating cell line identity | url = http://www.promega.com/cnotes/cn022/cn022_15.pdf | journal = Cell Notes | volume = 22 | issue = | pages = 15–17 | access-date = 2008-10-28 | archive-url = https://web.archive.org/web/20081028200822/http://www.promega.com/cnotes/cn022/cn022_15.pdf | archive-date = 2008-10-28 | dead-url = yes | df = }} 21. ^{{cite journal | vauthors = Nguyen HT, Geens M, Spits C | title = Genetic and epigenetic instability in human pluripotent stem cells | journal = Human Reproduction Update | volume = 19 | issue = 2 | pages = 187–205 | year = 2012 | pmid = 23223511 | pmc = | doi = 10.1093/humupd/dms048 }} 22. ^{{cite web|url=http://online.ceb.com/calcases/C3/51C3d120.htm |title=Moore v. Regents of University of California (1990) 51 C3d 120 |publisher=Online.ceb.com |date= |accessdate=2012-01-27}} 23. ^{{cite journal | vauthors = Hayflick L | title = A brief history of the mortality and immortality of cultured cells | journal = The Keio Journal of Medicine | volume = 47 | issue = 3 | pages = 174–82 | date = September 1998 | pmid = 9785764 | doi = 10.2302/kjm.47.174 | series = 3 }} 24. ^{{cite web|title=Worthington tissue guide|url=http://www.worthington-biochem.com/tissuedissociation/glossary.html|accessdate=2013-04-30}} 25. ^{{cite journal | vauthors = Qian L, Saltzman WM | title = Improving the expansion and neuronal differentiation of mesenchymal stem cells through culture surface modification | journal = Biomaterials | volume = 25 | issue = 7–8 | pages = 1331–7 | year = 2004 | pmid = 14643607 | doi = 10.1016/j.biomaterials.2003.08.013 }} 26. ^{{cite journal | vauthors = Maguire G | title = Therapeutics from Adult Stem Cells and the Hype Curve | journal = ACS Medicinal Chemistry Letters | volume = 7 | issue = 5 | pages = 441–3 | year = 2016 | pmid = 27190588 | pmc = 4867479 | doi = 10.1021/acsmedchemlett.6b00125 }} 27. ^1 {{cite journal | vauthors = Prieto D, Aparicio G, Sotelo-Silveira JR | title = Cell migration analysis: A low-cost laboratory experiment for cell and developmental biology courses using keratocytes from fish scales | journal = Biochemistry and Molecular Biology Education | volume = 45 | issue = 6 | pages = 475–482 | date = November 2017 | pmid = 28627731 | doi = 10.1002/bmb.21071 }} 28. ^{{cite journal | vauthors = Discher DE, Janmey P, Wang YL | title = Tissue cells feel and respond to the stiffness of their substrate | journal = Science | volume = 310 | issue = 5751 | pages = 1139–43 | date = November 2005 | pmid = 16293750 | doi = 10.1126/science.1116995 | citeseerx = 10.1.1.318.690 }} 29. ^{{cite journal | vauthors = Gilbert PM, Havenstrite KL, Magnusson KE, Sacco A, Leonardi NA, Kraft P, Nguyen NK, Thrun S, Lutolf MP, Blau HM | title = Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture | journal = Science | volume = 329 | issue = 5995 | pages = 1078–81 | date = August 2010 | pmid = 20647425 | pmc = 2929271 | doi = 10.1126/science.1191035 }} 30. ^{{cite journal | vauthors = Chowdhury F, Li Y, Poh YC, Yokohama-Tamaki T, Wang N, Tanaka TS | title = Soft substrates promote homogeneous self-renewal of embryonic stem cells via downregulating cell-matrix tractions | journal = PLOS One | volume = 5 | issue = 12 | pages = e15655 | date = December 2010 | pmid = 21179449 | pmc = 3001487 | doi = 10.1371/journal.pone.0015655 | editor1-last = Zhou | editor1-first = Zhongjun }} 31. ^{{cite journal | vauthors = Engler AJ, Sen S, Sweeney HL, Discher DE | title = Matrix elasticity directs stem cell lineage specification | journal = Cell | volume = 126 | issue = 4 | pages = 677–89 | date = August 2006 | pmid = 16923388 | doi = 10.1016/j.cell.2006.06.044 }} 32. ^{{cite journal | vauthors = Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D, Hammer DA, Weaver VM | title = Tensional homeostasis and the malignant phenotype | journal = Cancer Cell | volume = 8 | issue = 3 | pages = 241–54 | date = September 2005 | pmid = 16169468 | doi = 10.1016/j.ccr.2005.08.010 }} 33. ^{{cite journal | vauthors = Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL, Weaver VM | title = Matrix crosslinking forces tumor progression by enhancing integrin signaling | journal = Cell | volume = 139 | issue = 5 | pages = 891–906 | date = November 2009 | pmid = 19931152 | pmc = 2788004 | doi = 10.1016/j.cell.2009.10.027 }} 34. ^{{cite journal | vauthors = Tilghman RW, Cowan CR, Mih JD, Koryakina Y, Gioeli D, Slack-Davis JK, Blackman BR, Tschumperlin DJ, Parsons JT | title = Matrix rigidity regulates cancer cell growth and cellular phenotype | journal = PLOS One | volume = 5 | issue = 9 | pages = e12905 | date = September 2010 | pmid = 20886123 | pmc = 2944843 | doi = 10.1371/journal.pone.0012905 | editor1-last = Hotchin | editor1-first = Neil A }} 35. ^{{cite journal | vauthors = Liu F, Mih JD, Shea BS, Kho AT, Sharif AS, Tager AM, Tschumperlin DJ | title = Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression | journal = The Journal of Cell Biology | volume = 190 | issue = 4 | pages = 693–706 | date = August 2010 | pmid = 20733059 | pmc = 2928007 | doi = 10.1083/jcb.201004082 }} 36. ^{{cite journal | vauthors = Wipff PJ, Rifkin DB, Meister JJ, Hinz B | title = Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix | journal = The Journal of Cell Biology | volume = 179 | issue = 6 | pages = 1311–23 | date = December 2007 | pmid = 18086923 | pmc = 2140013 | doi = 10.1083/jcb.200704042 }} 37. ^{{cite journal | vauthors = Georges PC, Hui JJ, Gombos Z, McCormick ME, Wang AY, Uemura M, Mick R, Janmey PA, Furth EE, Wells RG | title = Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis | journal = American Journal of Physiology. Gastrointestinal and Liver Physiology | volume = 293 | issue = 6 | pages = G1147–54 | date = December 2007 | pmid = 17932231 | doi = 10.1152/ajpgi.00032.2007 }} 38. ^{{cite journal | vauthors = Li L, Sharma N, Chippada U, Jiang X, Schloss R, Yarmush ML, Langrana NA | title = Functional modulation of ES-derived hepatocyte lineage cells via substrate compliance alteration | journal = Annals of Biomedical Engineering | volume = 36 | issue = 5 | pages = 865–76 | date = May 2008 | pmid = 18266108 | doi = 10.1007/s10439-008-9458-3 }} 39. ^{{cite journal | vauthors = Semler EJ, Lancin PA, Dasgupta A, Moghe PV | title = Engineering hepatocellular morphogenesis and function via ligand-presenting hydrogels with graded mechanical compliance | journal = Biotechnology and Bioengineering | volume = 89 | issue = 3 | pages = 296–307 | date = February 2005 | pmid = 15744840 | doi = 10.1002/bit.20328 }} 40. ^{{cite journal | vauthors = Friedland JC, Lee MH, Boettiger D | title = Mechanically activated integrin switch controls alpha5beta1 function | journal = Science | volume = 323 | issue = 5914 | pages = 642–4 | date = January 2009 | pmid = 19179533 | doi = 10.1126/science.1168441 }} 41. ^{{cite journal | vauthors = Chan CE, Odde DJ | title = Traction dynamics of filopodia on compliant substrates | journal = Science | volume = 322 | issue = 5908 | pages = 1687–91 | date = December 2008 | pmid = 19074349 | doi = 10.1126/science.1163595 }} 42. ^{{cite journal | vauthors = Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, Elvassore N, Piccolo S | title = Role of YAP/TAZ in mechanotransduction | journal = Nature | volume = 474 | issue = 7350 | pages = 179–83 | date = June 2011 | pmid = 21654799 | doi = 10.1038/nature10137 }} 43. ^{{cite web|url=http://www.nature.com/drugdisc/news/articles/424870a.html |title=drug discovery@nature.com |publisher=Nature.com |date= |accessdate=2013-03-26}} 44. ^{{cite journal | vauthors = Duell BL, Cripps AW, Schembri MA, Ulett GC | title = Epithelial cell coculture models for studying infectious diseases: benefits and limitations | journal = Journal of Biomedicine & Biotechnology | volume = 2011 | pages = 1–9 | year = 2011 | pmid = 22007147 | pmc = 3189631 | doi = 10.1155/2011/852419 }} 45. ^{{cite journal | vauthors = Barrila J, Radtke AL, Crabbé A, Sarker SF, Herbst-Kralovetz MM, Ott CM, Nickerson CA | title = Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions | journal = Nature Reviews. Microbiology | volume = 8 | issue = 11 | pages = 791–801 | date = November 2010 | pmid = 20948552 | doi = 10.1038/nrmicro2423 }} 46. ^{{cite journal | vauthors = Edmondson R, Broglie JJ, Adcock AF, Yang L | title = Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors | journal = Assay and Drug Development Technologies | volume = 12 | issue = 4 | pages = 207–18 | year = 2014 | pmid = 24831787 | pmc = 4026212 | doi = 10.1089/adt.2014.573 }} 47. ^{{cite journal | vauthors = Bhattacharya M, Malinen MM, Lauren P, Lou YR, Kuisma SW, Kanninen L, Lille M, Corlu A, GuGuen-Guillouzo C, Ikkala O, Laukkanen A, Urtti A, Yliperttula M | title = Nanofibrillar cellulose hydrogel promotes three-dimensional liver cell culture | journal = Journal of Controlled Release | volume = 164 | issue = 3 | pages = 291–8 | year = 2012 | pmid = 22776290 | doi = 10.1016/j.jconrel.2012.06.039 }} 48. ^{{cite journal | vauthors = DeRosa MC, Monreal C, Schnitzer M, Walsh R, Sultan Y | title = Nanotechnology in fertilizers | journal = Nature Nanotechnology | volume = 5 | issue = 2 | pages = 91 | date = February 2010 | pmid = 20130583 | doi = 10.1038/nnano.2010.2 }} 49. ^{{cite journal | vauthors = Hsiao AY, Tung YC, Qu X, Patel LR, Pienta KJ, Takayama S | title = 384 hanging drop arrays give excellent Z-factors and allow versatile formation of co-culture spheroids | journal = Biotechnology and Bioengineering | volume = 109 | issue = 5 | pages = 1293–304 | date = May 2012 | pmid = 22161651 | pmc = 3306496 | doi = 10.1002/bit.24399 }} 50. ^{{Cite web|url=https://www.researchgate.net/publication/317053872|title=NIH Phase I Final Report: Fibrous Substrates for Cell Culture (R3RR03544A) (PDF Download Available)|last=Simon|first=Eric M. | name-list-format = vanc | date = 1988 | website=ResearchGate|access-date=2017-05-22}} 51. ^{{cite journal | vauthors = Tibbitt MW, Anseth KS | title = Hydrogels as extracellular matrix mimics for 3D cell culture | journal = Biotechnology and Bioengineering | volume = 103 | issue = 4 | pages = 655–63 | year = 2009 | pmid = 19472329 | pmc = 2997742 | doi = 10.1002/bit.22361 }} 52. ^{{cite web|url=https://www.wired.com/news/wireservice/0,70102-0.html?tw=wn_index_7 |publisher=Wired.com|title=Quickie Bird Flu Vaccine Created|date=2006-01-26|author=Reuters|work=Wired|accessdate=2010-01-31}} 53. ^{{cite journal | vauthors = Gao W, Soloff AC, Lu X, Montecalvo A, Nguyen DC, Matsuoka Y, Robbins PD, Swayne DE, Donis RO, Katz JM, Barratt-Boyes SM, Gambotto A | title = Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization | journal = Journal of Virology | volume = 80 | issue = 4 | pages = 1959–64 | date = February 2006 | pmid = 16439551 | pmc = 1367171 | doi = 10.1128/JVI.80.4.1959-1964.2006 }} 54. ^{{cite web|url=https://www.niaid.nih.gov/news/newsreleases/2004/pages/h9n2.aspx|title=NIAID Taps Chiron to Develop Vaccine Against H9N2 Avian Influenza|date=2004-08-17|work=National Institute of Allergy and Infectious Diseases (NIAID)|accessdate=2010-01-31}} 55. ^{{cite journal | vauthors = Rapanan JL, Cooper KE, Leyva KJ, Hull EE | title = Collective cell migration of primary zebrafish keratocytes | journal = Experimental Cell Research | volume = 326 | issue = 1 | pages = 155–65 | date = August 2014 | pmid = 24973510 | doi = 10.1016/j.yexcr.2014.06.011 }} 56. ^{{cite journal | vauthors = Lee J, Jacobson K | title = The composition and dynamics of cell-substratum adhesions in locomoting fish keratocytes | journal = Journal of Cell Science | volume = 110 ( Pt 22) | pages = 2833–44 | date = November 1997 | pmid = 9427291 }} 57. ^{{cite journal | vauthors = Hunt P, Robertson D, Weiss D, Rennick D, Lee F, Witte ON | title = A single bone marrow-derived stromal cell type supports the in vitro growth of early lymphoid and myeloid cells | journal = Cell | volume = 48 | issue = 6 | pages = 997–1007 | date = March 1987 | pmid = 2435412 | doi = 10.1016/0092-8674(87)90708-2 }} 58. ^{{cite journal | vauthors = van den Berg-Bakker CA, Hagemeijer A, Franken-Postma EM, Smit VT, Kuppen PJ, van Ravenswaay Claasen HH, Cornelisse CJ, Schrier PI | title = Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: growth features and cytogenetics | journal = International Journal of Cancer | volume = 53 | issue = 4 | pages = 613–20 | date = February 1993 | pmid = 8436435 | doi = 10.1002/ijc.2910530415 }} 59. ^{{cite journal | vauthors = Lee YG, Korenchuk S, Lehr J, Whitney S, Vessela R, Pienta KJ | title = Establishment and characterization of a new human prostatic cancer cell line: DuCaP | journal = In Vivo | volume = 15 | issue = 2 | pages = 157–62 | year = 2001 | pmid = 11317521 }} 60. ^{{cite journal | vauthors = Ou D, Mitchell LA, Décarie D, Tingle AJ, Nepom GT | title = Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype | journal = Human Immunology | volume = 59 | issue = 3 | pages = 149–57 | date = March 1998 | pmid = 9548074 | doi = 10.1016/S0198-8859(98)00006-8 }} Further reading{{refbegin}}
External links{{Library resources box|onlinebooks=no |by=no |lcheading=Cell culture}}
5 : Biotechnology|Cell biology|Cell culture|Molecular biology techniques|Alternatives to animal testing |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。